A possible alternate lower cost HCC surveillance strategy consisting of only an annual ultrasound and biannual AFP would be cost-effective and could be considered for patients who have a lower HCC risk (≥ 0.3%/yr) including Asian men over 40 years and Asian women over 50 years. Here, AFP is linked to hepatocellular carcinoma.